Progen Industries Ltd. (Nasdaq: PGLA) 115% HGHER; Announced positive preliminary results from its Phase II clinical trial of PI-88 for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE